Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

@article{Cortese2013PractitionerRC,
  title={Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.},
  author={Samuele Cortese and Martin Holtmann and Tobias Banaschewski and Jan K. Buitelaar and David R. Coghill and Marina Danckaerts and Ralf W. Dittmann and John G. I. Graham and Eric Taylor and Joseph A. Sergeant},
  journal={Journal of child psychology and psychiatry, and allied disciplines},
  year={2013},
  volume={54 3},
  pages={
          227-46
        }
}
BACKGROUND Medication is an important element of therapeutic strategies for ADHD. While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs. The aim of this review is to provide evidence- and expert-based guidance concerning the management of (AEs) with medications for ADHD. METHODS For ease of use by practitioners and clinicians, the article is organized in a simple question… 

Figures and Tables from this paper

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
TLDR
The current evidence for ADHD is summarized and several methodological issues and gaps in the current evidence that are important for clinicians to consider when evaluating the evidence and making treatment decisions are identified.
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder
TLDR
Parent training is an important part of the multimodal treatment of children with ADHD, which improves parenting, reduces levels of oppositional and noncompliant behaviours and may improve other aspects of functioning, however, blinded evidence does not support it as a specific treatment for core ADHD symptoms.
Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis
TLDR
The summarized evidence suggests that headache is common in children with ADHD, both as part of the clinical presentation as such and as a side effect of some standard medications.
Managing the Risks of ADHD Treatments
TLDR
The relevant data on the significance and prevalence of side effects and adverse events are discussed, recent updates in the field are highlighted, and approaches to clinical management are suggested.
Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD
TLDR
Concerns exist about cardiovascular and psychiatric AEs, even if the available evidence does not support an association with medications, and effective drugs for ADHD appears to be safe and well tolerated.
Safety of medicines used for ADHD in children: a review of published prospective clinical trials
TLDR
Few studies evaluated the long-term safety of drugs for ADHD, andeterogeneity in follow-up duration and in data reporting made comparing different studies and drugs difficult.
Regular medication reviews for children and young people with ADHD
TLDR
Children and young people with a diagnosis of ADHD receiving stimulant medications are required to attend regular review appointments with a consultant child and adolescent psychiatrist or specialist nurse under shared care guidelines with general practices.
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
TLDR
This article supports the recommendations of the clinical practice guideline and accompanying process of care algorithm for diagnosis and treatment of comorbid conditions in children and adolescents with ADHD.
Attention-Deficit/Hyperactivity Disorder in Looked-After Children: a Systematic Review of the Literature
TLDR
The vast majority of the retained studies are from the USA and show rates of ADHD and of its pharmacological treatment substantially higher in LAC than those reported in national estimates.
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder.
  • L. Briars, Timothy J. Todd
  • Psychology, Medicine
    The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
  • 2016
TLDR
This review focuses on the clinical use of psychostimulant medication in children and adolescents and the pharmacodynamic and pharmacokinetic differences between the newest long-acting formulations as well as commonly encountered adverse drug reactions.
...
...

References

SHOWING 1-10 OF 113 REFERENCES
A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
TLDR
Although both stimulant and nonstimulant medications are effective for treating ADHD in adults, stimulant medications show greater efficacy for the short durations of treatment characteristic of placebo-controlled studies.
Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder
TLDR
Current evidence suggests that, for the majority of those treated for ADHD, the medications currently available pose little in the way of risk of significant harm, and potential but unlikely long-term treatment effects need to be investigated as carefully as possible.
Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
TLDR
Methylphenidate seems to offer the greatest and most immediate improvement of ADHD symptoms and does not seem to worsen tic symptoms, and alpha-2 agonists offer the best combined improvement in both tic and ADHD symptoms.
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
TLDR
There was no statistically significant association between use of atomoxetine or stimulants and seizure risk in children ages 6 to 17 years with ADHD and without prior seizure disorder.
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.
TLDR
Short-acting methylphenidate has a statistically significant clinical effect in the short-term treatment of individuals with a diagnosis of ADD aged 18 years and less, however, the extension of this placebo-controlled effect beyond 4 weeks of treatment has not been demonstrated.
Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications.
TLDR
The data indicate that the majority of ADHD individuals, particularly those without conduct or substance use disorders, use their medications appropriately, and the need to monitor medication use in ADHD individuals with conduct and/or Substance use disorders is highlighted.
Pharmacological treatment of ADHD and the short and long term effects on sleep.
TLDR
It is imperative to understand the effects of ADHD medications on sleep while prescribing either CNS stimulants or non-CNS stimulants, and the relevant data discussing their short- and long-term effects on sleep are provided.
...
...